Effect of MK-801 on gene expressions in the amygdala of rats

Synapse

Volumn 62, Issue 1, 2008, Pages 1-7

  Matsuoka, Tadasu ^a   Tsunoda, Masahiko ^a   Sumiyoshi, Tomiki ^a,b   Takasaki, Ichiro ^a   Tabuchi, Yoshiaki ^a   Seo, Tomonori ^a   Tanaka, Kodai ^a   Uehara, Takashi ^a   Itoh, Hiroko ^a   Suzuki, Michio ^a,b   Kurachi, Masayoshi ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Arginine vasopressin; Glutamatergic; Microarray; NMDA; Real time pcr; Schizophrenia; Social interaction

Indexed keywords

ARACHIDONIC ACID; ARGIPRESSIN; DIZOCILPINE; HORMONE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTROPIC AGENT; PREALBUMIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AVP GENE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENPP2 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; IGFBP2 GENE; LOCOMOTION; MALE; MICROARRAY ANALYSIS; MOBP GENE; MYELINATION; NERVE TRACT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; PTGDS GENE; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SSTR2 GENE; TTR GENE; WISTAR RAT;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; MALE; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 36348930492     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20455     Document Type: Article

References (42)

1. Aston C, Jiang L, Sokolov BP. 2004. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77:858-866.
2. Bezchlibnyk YB, Wang JF, Shao L, Young LT. 2006. Insulin-like growth factor binding protein-2 expression is decreased by lithium. Neuroreport 17:897-901.
3. Breese GR, Knapp DJ, Moy SS. 2002. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: Potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci Biobehav Rev 26:441-455.
4. Crow TJ. 1980. Molecular pathology of schizophrenia: More than one disease process? Br Med J 280:66-68.
5. Essig EC, Kilpatrick IC. 1991. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala. Psychopharmacology (Berl) 104:194-200.
6. Fox MA, Colello RJ, Macklin WB, Fuss B. 2003. Phosphodiesterase-Ialpha/ autotaxin: A counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci 23:507-519.
7. Hagino H, Tabuchi E, Kurachi M, Saitoh O, Sun Y, Kondoh T, Ono T, Torii K. 1998. Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging. Brain Res 813:367-373.
8. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746-4751.
9. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
10. Holz A, Schaeren-Wiemers N, Schaefer C, Pott U, Colello RJ, Schwab ME. 1996. Molecular and developmental characterization of novel cDNAs of the myelin-associated/oligodendrocytic basic protein. J Neurosci 16:467-477.
11. Insel TR. 1997. A neurobiological basis of social attachment. Am J Psychiatry 154:726-735.
12. Javitt DC. 2004. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 9:984-997, 979.
13. Kaiser S, Foltz LA, George CA, Kirkwood SC, Bemis KG, Lin X, Gelbert LM, Nisenbaum LK. 2004. Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia. Neurobiol Dis 16:220-235.
14. Kohda K, Jinde S, Iwamoto K, Bundo M, Kato N, Kato T. 2006. Maternal separation stress drastically decreases expression of transthyretin in the brains of adult rat offspring. Int J Neuropsychopharmacol 9:201-208.
15. Kurachi M. 2003. Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis. Psychiatry Clin Neurosci 57:9-15.
16. Kurachi M, Yasui S, Shibata R, Murata M, Hagino H, Kurachi T, Tanii Y, Kurata K. 1994. Comparative study of dopamine metabolism with local cerebral glucose utilization in rat brain following the administration of haloperidol decanoate. Biol Psychiatry 36:110-117.
17. Kurachi M, Shibata R, Murata M, Tanii Y. 1995. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration. Biol Psychiatry 37:487-490.
18. Li Z, Kim CH, Ichikawa J, Meltzer HY. 2003. Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice. Pharmacol Biochem Behav 75:335-340.
19. Marvanova M, Lakso M, Wong G. 2004. Identification of genes regulated by memantine and MK-801 in adult rat brain by cDNA microarray analysis. Neuropsychopharmacology 29:1070-1079.
20. Matsuoka T, Sumiyoshi T, Tanaka K, Tsunoda M, Uehara T, Itoh H, Kurachi M. 2005. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: Therapeutic implications for schizophrenia. Brain Res 1053:131-136.
21. Moghaddam B, Jackson ME. 2003. Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003:131-137.
22. Nemeroff CB, Youngblood WW, Manberg PJ, Prange AJ Jr, Kizer JS. 1983. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science 221:972-975.
23. Nishino S, Mignot E, Benson KL, Zarcone VP Jr. 1998. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: Relationship to sleep architecture. Psychiatry Res 78:141-150.
24. O'Donnell J, Stemmelin J, Nitta A, Brouillette J, Quirion R. 2003. Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats. Synapse 50:171-180.
25. Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A, Eriksson PS, Blennow K, Davidsson P. 2003. Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res 71:526-533.
26. Pizzolato G, Soncrant TT, Larson DM, Rapoport SI. 1985. Reduced metabolic response of the rat brain to haloperidol after chronic treatment. Brain Res 337:1-9.
27. Reynolds GP. 1983. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305:527-529.
28. Reynolds GP. 1989. Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia. Br J Psychiatry 155:305-316.
29. Rung JP, Carlsson A, Ryden Markinhuhta K, Carlsson ML. 2005. (+)-MK-801 induced social withdrawal in rats: A model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:827-832.
30. Sams-Dodd F. 1995a. Automation of the social interaction test by a video-tracking system: Behavioural effects of repeated phencyclidine treatment. J Neurosci Methods 59:157-167.
31. Sams-Dodd F. 1995b. Distinct effects of D-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65.
32. Sams-Dodd F. 1996. Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia. Behav Pharmacol 7:3-23.
33. Sams-Dodd F. 1998. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology 19:18-25.
34. Schulz B, Fendt M, Pedersen V, Koch M. 2001. Sensitization of pre-pulse inhibition deficits by repeated administration of dizocilpine. Psychopharmacology (Berl) 156:177-181.
35. Stork O, Stork S, Pape HC, Obata K. 2001. Identification of genes expressed in the amygdala during the formation of fear memory. Learn Mem 8:209-219.
36. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Uehara T, Kurachi M, Meltzer HY. 2000. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia. J Clin Psychopharmacol 20:386-388.
37. Sumiyoshi T, Matsui M, Itoh H, Higuchi Y, Arai H, Takamiya C, Kurachi M. 2006. Essential polyunsaturated fatty acids and social cognition in schizophrenia. Psychiatry Res (in press).
38. Sun YJ, Suzuki M, Kurachi T, Murata M, Kurachi M. 1998. Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate. Brain Res 791:125-136.
39. Tanaka K, Suzuki M, Sumiyoshi T, Murata M, Tsunoda M, Kurachi M. 2003. Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat. Brain Res 992:239-245.
40. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. 2003. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8:592-610.
41. Wolf ME, Khansa MR. 1991. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
42. Wong AH, Lipska BK, Likhodi O, Boffa E, Weinberger DR, Kennedy JL, Van Tol HH. 2005. Cortical gene expression in the neonatal ventral-hippocampal lesion rat model. Schizophr Res 77:261-270.